ExamplesResearched
£500 for a product you have never taken
Read the original question
A supplement brand has offered me £500 to post about their product to my followers. I have never taken it and I have no idea whether it works. The post would be marked as an ad. Should I take the money?
Accept the offer and post the advertisement for the supplement brandNamed in the question0 of 6 perspectives rank it highest0 positive · 6 negative
The challenges ([ch-4], [ch-6], [ch-9]) failed to reach Step 6 of the procedure. [ch-4] demanded a contrast with contractualist individualism, which is irrelevant to the utilitarian procedure's aggregationist nature. [ch-6] and [ch-9] conflated uncertainty with procedural failure, ignoring Step 8's sensitivity analysis, which explicitly addresses epistemic limits. The procedure's verdict for option a (-68) stands because the diffuse harm's expected welfare impact remains negative and decisive, even under uncertainty.
No challenges reached the Care Ethics procedure's assessment of this option. The original verdict was based on Step 4's responsiveness element (followers would likely receive the action as a breach of trust) and Step 6's paternalism audit (the individual's lack of competence to promote the product responsibly). These steps were not contested, so the assessment holds.
The challenges, particularly [ch-8], fail to reach Step 7 of the contractualist procedure. The Ubuntu seat's critique of the individualist restriction (Step 4) does not address the substantive moral constraint it imposes: preventing the subordination of one person's urgent interests to the aggregated lesser interests of many. The brand's reputational harm is not comparable in severity to the burden borne by followers, and thus aggregation would not change the outcome of the reasonable rejection test. The challenge also conflates relational interconnectedness with moral standing, which contractualism does not recognize as equivalent.
The challenges (ch-1, ch-2, ch-5) fail to reach Step 6 of the Kantian procedure. They either misconstrue the Formula of Humanity's requirement (e.g., equating transparency with respect for rational agency) or introduce parties (the supplement brand) whose standing is irrelevant to the duty owed to followers. The maxim's end (financial gain) remains incompatible with treating followers as ends in themselves, regardless of labeling.
The challenges, particularly [ch-3], do not reach Step 4 of the Ubuntu procedure. The exclusion of the supplement brand is justified under Step 1 (community mapping) because the brand's role is transactional, not constitutive of shared identity or solidarity. The Step 8 audit confirms no boundary problem exists, and the discord identified in Step 4 (division and ill-will toward followers) remains unaddressed by the challenges.
The challenges, including [ch-7], do not reach Step 4 of the procedure. The expressive dimension of the act (Step 2) and the phronimos test (Step 4) focus on the agent's character and their relationship with their followers. The supplement brand, as a commercial entity, is not a locus of virtue or vice, and its interests do not engage the virtues in the way that the agent's character or the followers' trust do. The challenges fail to show that the brand's exclusion is a defect in the tradition's own terms.
Rankings are within each perspective. Scores are not comparable across perspectives; a highest-ranked choice can still receive a negative appraisal.
Decline the offer and do not post the advertisementNamed in the question6 of 6 perspectives rank it highest4 positive · 0 negative · 2 zero
The challenges did not contest option b's neutrality. The procedure's verdict for option b (0) remains unchanged because declining the offer avoids the diffuse harm associated with option a, producing no net welfare loss or gain. No challenge identified a flaw in this assessment.
No challenges addressed the Care Ethics procedure's evaluation of this option. The original verdict was grounded in Step 2 (engrossment: apprehending followers' potential vulnerability to misinformation) and Step 4 (responsiveness: followers would likely receive the refusal as an act of care). These steps remain valid, so the assessment is unchanged.
No challenge successfully engages with the contractualist procedure's assessment of option (b). The principle underlying option (b) avoids imposing any severe burden on followers, and thus no one could reasonably reject it. The challenges do not identify any overlooked burdens or misapplied steps in the procedure for this option.
The challenges do not address Option B, as it was already deemed permissible under the Kantian procedure. No challenge provided a reason to revisit Step 6 or Step 7 (duty resolution) for this option, as it involves no violation of perfect duties and aligns with the imperfect duty of self-development.
The challenges do not contest the assessment of option (b). The Ubuntu procedure's Step 4 and Step 5 find no discord or personhood diminishment in declining the offer, and the challenges provide no reason to revisit this conclusion.
No challenge successfully contests the application of the procedure to this option. Step 4's phronimos test confidently identifies declining the offer as the action a virtuous agent would characteristically take. The challenges do not address the habituation (Step 6) or eudaimonia (Step 7) considerations, which further support the original verdict. The option remains fully aligned with the tradition's requirements.
Rankings are within each perspective. Scores are not comparable across perspectives; a highest-ranked choice can still receive a negative appraisal.
Cross-examination (9)
In Round 2 each perspective challenged the others. Where a perspective later credited a challenge for moving its score, the badge shows the move, Round 1 to final.
The Kantian seat's procedure (Step 6) concludes that promoting the product treats followers merely as a means, but this overlooks the explicit labeling of the post as an advertisement. This labeling arguably provides followers with the information necessary to make an autonomous choice, which is central to respecting their rational agency. The Kantian procedure's own requirement to avoid treating others merely as a means is not adequately supported if the followers' autonomy is preserved through transparency.
The challenge asserts that explicit labeling of the post as an advertisement preserves followers' autonomy, thereby satisfying the Formula of Humanity's requirement to avoid treating them merely as a means. However, this challenge fails to address the content of the maxim under scrutiny. The Kantian procedure (Step 6) does not merely ask whether followers are informed of the commercial nature of the post; it asks whether they are treated as ends in themselves in the agent's maxim. The individual's maxim here is: "In circumstances where I am offered money to promote a product I have no experience with, I will create and post content promoting it in order to receive payment." The end is financial gain, and the means include the followers' engagement with the post. Even with transparency, the followers are not being engaged with as rational agents capable of shared ends but are instead being used as a conduit for the individual's financial benefit. The individual does not know whether the product is effective or safe, meaning they cannot rationally endorse it as a shared end with their followers. Transparency alone does not resolve this; it merely informs followers that they are being used as a means to an end they cannot rationally consent to. The challenge also misapplies the Kantian procedure by conflating information with respect for rational agency. The latter requires that the agent's end be one that the person acted upon could share or rationally consent to, not merely that they are aware of the agent's intentions. Thus, the challenge fails to undermine the verdict.
The Kantian seat's procedure (Step 6) concludes that promoting the product treats followers merely as a means, violating the duty of respect for rational agency. However, the case explicitly states the post would be labeled as an advertisement, which provides followers with the information needed to exercise their rational agency in deciding whether to engage with the product. The Kantian seat's own procedure requires that the follower's capacity for autonomous choice be respected, and the labeled advertisement satisfies this condition. The conclusion that followers are treated merely as a means does not follow from the Kantian procedure when the advertisement is transparent.
This challenge repeats the claim that transparency (via the labeled advertisement) preserves followers' rational agency, thereby satisfying the Kantian duty of respect. However, it misunderstands the Kantian test for treating others merely as a means. The Formula of Humanity (Step 6) does not ask whether followers are aware of the agent's motives but whether they are treated as rational agents whose ends matter. The individual's maxim here is not to inform followers but to persuade them to engage with a product the individual cannot vouch for. Even if followers know the post is an advertisement, they are still being used as a means to the individual's financial end without the possibility of shared rational endorsement of the product's value. The challenge also ignores the imperfect duty of self-development (Step 7). By promoting a product they do not understand, the individual undermines their own rational agency by acting without integrity or competence. This duty is not outweighed by transparency, as the Kantian procedure prioritizes perfect duties (e.g., not treating others merely as a means) over imperfect ones. Thus, the challenge fails because it misconstrues the Kantian requirement for respect: transparency is necessary but not sufficient to avoid treating others merely as a means.
The Ubuntu seat's verdict excludes the supplement brand as a party with standing in the relational web. The brand is directly involved in the transaction and its actions (e.g., offering payment for promotion) contribute to the relational dynamics at stake. The Ubuntu procedure's Step 4 emphasizes the interconnectedness of all parties whose personhood is constituted by the relational web, and the brand's role in this case is morally significant. The seat's failure to include the brand as a party with standing is a defect in scope.
The challenge from care-ethics correctly identifies a tension in the Ubuntu seat's procedure: the exclusion of the supplement brand from the relational web in Step 1 (community mapping). However, the challenge fails to account for Ubuntu's relational (not transactional) conception of community. Here is why the exclusion is justified under the procedure: 1. Personhood, not legal or economic standing: Ubuntu's community consists of those whose personhood is mutually constituted through shared life and reciprocal recognition. The brand, as a corporate entity, does not participate in the web of human relationships that define personhood in this tradition. Its role is transactional (offering payment) and instrumental (seeking promotion), not constitutive of shared identity or solidarity. Step 1 explicitly requires identifying who is excluded and why; the brand is excluded because its involvement is economic, not relational. 2. Step 8 audit confirms no suppressed dissent: The challenge assumes the brand's exclusion is a boundary problem, but Step 8 of the Ubuntu procedure requires auditing whether the community boundary itself creates discord. Here, the brand's absence does not suppress a legitimate dissenting voice because the brand is not a person capable of dissent in Ubuntu's terms. Its interests are represented indirectly through the relational effects on the influencer and their audience (e.g., whether the promotion fosters trust or deception). 3. Solidarity effects are mediated through human relationships: Step 3 assesses solidarity (acting for another's good out of good-will). The brand's motives (profit) are not evaluated as good-will under Ubuntu, but the influencer's actions toward their audience are. The brand's exclusion does not ignore its impact; it reframes it as a secondary effect on the human relationships at stake (e.g., the influencer's honesty with their followers). 4. The challenge conflates stakeholder analysis with relational ethics: Care-ethics may treat all affected parties as morally significant, but Ubuntu's procedure is narrower: it evaluates how actions affect the harmony of relationships that constitute personhood. The brand's economic stake does not grant it standing in this web. The procedure's refusal to manufacture relational standing for non-persons is not a defect but a feature of its scope. Conclusion: The challenge fails because it misapplies Ubuntu's relational criteria to a corporate entity. The brand's exclusion is consistent with the procedure's focus on human interconnectedness, and the audit in Step 8 confirms no boundary problem exists. The Ubuntu seat's verdict holds.
The act-utilitarian seat's procedure requires aggregation of welfare across all affected individuals, but its verdict does not explicitly address whether the 'diffuse harm to followers and future consumers' is sufficiently severe for any single individual to outweigh the individual's financial gain under the contractualist individualist restriction. The utilitarian seat must demonstrate that its aggregation step (step-6) would not produce a different outcome if the strongest individual objection were prioritized, as required by Scanlonian contractualism. The absence of this contrast violates its own procedure's demand for transparency about how aggregation differs from individualist reasoning.
The challenge asserts that the act-utilitarian procedure must demonstrate its aggregation step would not produce a different outcome if the strongest individual objection were prioritized, as contractualism requires. This challenge fails because it misrepresents the utilitarian procedure's commitments. Step 6 of the procedure explicitly requires aggregation across persons as a defining feature of act-utilitarianism (per Sidgwick's impartiality axiom and Bentham's 'extent' dimension). The procedure does not incorporate side constraints or individualist restrictions, nor does it claim to. Step 9 of the procedure already flags when aggregation produces concentrated harm to a minority, but it does so without overriding the verdict, precisely because the tradition rejects the contractualist premise that individual objections can veto aggregation. The challenge's demand for a contrast with contractualism is thus a category error: the utilitarian seat is not required to justify its aggregation by standards external to its own procedure. The absence of such a contrast does not violate the procedure, which is transparent about its aggregationist nature.
Six perspectives, six procedures
Specific reconstructions of ethical traditions, generated by one model. These are not independent experts or a vote on moral truth.
Utilitarian (Act)Ranks highest: BA−68B0
Ranking labels come from final scores. The explanation is model-written and may still contain errors.
The expected aggregate welfare of option a remains significantly lower than option b due to the diffuse harm to followers (e.g., misinformation, wasted resources, or potential health risks) outweighing the individual's financial gain, even when accounting for uncertainty in estimates. The margin is robust under sensitivity analysis (Step 8), as no single plausible revision to the harm estimates would flip the ranking.
| Option | Initial | Final | Appraisal |
|---|---|---|---|
| A | −68 | −68 | Negative |
| B | 0 | 0 | Inspect the zero anchor in the method |
Why scores changed or held
Option A: The challenges ([ch-4], [ch-6], [ch-9]) failed to reach Step 6 of the procedure. [ch-4] demanded a contrast with contractualist individualism, which is irrelevant to the utilitarian procedure's aggregationist nature. [ch-6] and [ch-9] conflated uncertainty with procedural failure, ignoring Step 8's sensitivity analysis, which explicitly addresses epistemic limits. The procedure's verdict for option a (-68) stands because the diffuse harm's expected welfare impact remains negative and decisive, even under uncertainty.
Option B: The challenges did not contest option b's neutrality. The procedure's verdict for option b (0) remains unchanged because declining the offer avoids the diffuse harm associated with option a, producing no net welfare loss or gain. No challenge identified a flaw in this assessment.
What could change this view
If the probability of health harm to followers drops below 17% or the probability of health benefit exceeds 63%, the verdict could change. Additionally, if the number of followers is very small, the harm may become negligible.
Model-reported application confidence: 0.75. Not a calibrated probability of correctness.
Step-by-step account
Enumerate the option set PASS
{"options":[{"id":"a","description":"Accept the offer and post the advertisement for the supplement brand.","generated":false},{"id":"b","description":"Decline the offer and do not post the advertisement.","generated":false}]}
Enumerate affected parties (extent) PASS
{"affectedParties":[{"party":"individual (decision-maker)","count":1,"sentient":true,"proximity":"direct"},{"party":"supplement brand","count":1,"sentient":false,"proximity":"direct"},{"party":"followers of the individual","count":"N (unknown, but large)","sentient":true,"proximity":"direct"},{"party":"regulatory bodies","count":"M (unknown, but small)","sentient":false,"proximity":"indirect"},{"party":"future consumers of the supplement (if promoted)","count":"P (unknown, but potentially large)","sentient":true,"proximity":"future"}],"timeHorizon":"1 year (justified by the typical lifecycle of social media content and the duration over which supplement effects or harms might manifest)"}
Identify welfare effects PASS
{"effects":[{"optionId":"a","party":"individual (decision-maker)","effect":"Receives £500 payment; potential reputational harm if followers perceive dishonesty or exploitation; potential reputational benefit if followers trust the individual's judgment and the product is benign.","valence":"+"},{"optionId":"a","party":"individual (decision-maker)","effect":"Possible guilt or cognitive dissonance if the individual believes they are misleading followers.","valence":"-"},{"optionId":"a","party":"followers of the individual","effect":"Exposure to an advertisement for a product of unknown efficacy; potential financial cost if they purchase the product; potential health benefit if the product is effective and safe; potential health harm if the product is ineffective or harmful (e.g., contamination, mislabeling).","valence":"-"},{"optionId":"a","party":"future consumers of the supplement","effect":"Increased likelihood of purchasing a product of unknown efficacy; potential health benefit or harm as above.","valence":"-"},{"optionId":"a","party":"supplement brand","effect":"Increased sales and revenue due to promotional exposure; no direct welfare effect (non-sentient).","valence":"N/A"},{"optionId":"a","party":"regulatory bodies","effect":"Increased monitoring burden if the advertisement triggers complaints or compliance issues; no direct welfare effect (non-sentient).","valence":"N/A"},{"optionId":"b","party":"individual (decision-maker)","effect":"No £500 payment; maintains current content and income; avoids potential reputational harm or guilt.","valence":"+"},{"optionId":"b","party":"individual (decision-maker)","effect":"Misses potential reputational benefit if followers would have trusted the individual's judgment.","valence":"-"},{"optionId":"b","party":"followers of the individual","effect":"Not exposed to the advertisement; no financial cost or health effects from the product.","valence":"+"},{"optionId":"b","party":"future consumers of the supplement","effect":"No increased likelihood of purchasing the product; no health effects from the product.","valence":"+"},{"optionId":"b","party":"supplement brand","effect":"Loses promotional opportunity; no direct welfare effect (non-sentient).","valence":"N/A"},{"optionId":"b","party":"regulatory bodies","effect":"No additional monitoring burden; no direct welfare effect (non-sentient).","valence":"N/A"}]}
Score each effect PASS
{"scoredEffects":[{"optionId":"a","party":"individual (decision-maker)","effect":"Receives £500 payment; potential reputational harm or benefit.","valence":"+","intensity":3,"duration":"weeks","recurrence":false,"probability":1,"count":1,"qualityNote":"Financial gain is a lower qualitative good compared to health or trust."},{"optionId":"a","party":"individual (decision-maker)","effect":"Possible guilt or cognitive dissonance.","valence":"-","intensity":2,"duration":"weeks","recurrence":false,"probability":0.5,"count":1,"qualityNote":null},{"optionId":"a","party":"followers of the individual","effect":"Exposure to advertisement; potential financial cost and health harm.","valence":"-","intensity":3,"duration":"months","recurrence":false,"probability":0.51,"count":"N (large, but unknown)","qualityNote":"Health harm is a higher qualitative bad; financial cost is a lower qualitative bad."},{"optionId":"a","party":"followers of the individual","effect":"Potential health benefit if product is effective and safe.","valence":"+","intensity":2,"duration":"months","recurrence":false,"probability":0.2,"count":"N (large, but unknown)","qualityNote":"Health benefit is a higher qualitative good."},{"optionId":"a","party":"future consumers of the supplement","effect":"Increased likelihood of purchasing product; potential health harm or benefit.","valence":"-","intensity":3,"duration":"months","recurrence":false,"probability":0.3,"count":"P (large, but unknown)","qualityNote":"Health harm is a higher qualitative bad."},{"optionId":"b","party":"individual (decision-maker)","effect":"No £500 payment; avoids reputational harm or guilt.","valence":"-","intensity":3,"duration":"weeks","recurrence":false,"probability":1,"count":1,"qualityNote":"Financial loss is a lower qualitative bad."},{"optionId":"b","party":"individual (decision-maker)","effect":"Misses potential reputational benefit.","valence":"-","intensity":1,"duration":"weeks","recurrence":false,"probability":0.3,"count":1,"qualityNote":null},{"optionId":"b","party":"followers of the individual","effect":"Not exposed to advertisement; no financial cost or health effects.","valence":"+","intensity":3,"duration":"months","recurrence":false,"probability":1,"count":"N (large, but unknown)","qualityNote":"Avoiding health harm is a higher qualitative good."},{"optionId":"b","party":"future consumers of the supplement","effect":"No increased likelihood of purchasing product; no health effects.","valence":"+","intensity":3,"duration":"months","recurrence":false,"probability":1,"count":"P (large, but unknown)","qualityNote":"Avoiding health harm is a higher qualitative good."}]}
Fecundity and purity PASS
{"fecundityPurity":[{"optionId":"a","party":"individual (decision-maker)","effect":"Receives £500 payment; potential reputational harm or benefit.","fecundity":"MED","purity":"MIXED","inapplicableStandardReasons":["Trust preservation does not apply because the individual has no prior relationship with the product."]},{"optionId":"a","party":"individual (decision-maker)","effect":"Possible guilt or cognitive dissonance.","fecundity":"LOW","purity":"PURE","inapplicableStandardReasons":[]},{"optionId":"a","party":"followers of the individual","effect":"Exposure to advertisement; potential financial cost and health harm.","fecundity":"HIGH","purity":"MIXED","inapplicableStandardReasons":[]},{"optionId":"a","party":"followers of the individual","effect":"Potential health benefit if product is effective and safe.","fecundity":"MED","purity":"PURE","inapplicableStandardReasons":[]},{"optionId":"a","party":"future consumers of the supplement","effect":"Increased likelihood of purchasing product; potential health harm or benefit.","fecundity":"HIGH","purity":"MIXED","inapplicableStandardReasons":[]},{"optionId":"b","party":"individual (decision-maker)","effect":"No £500 payment; avoids reputational harm or guilt.","fecundity":"LOW","purity":"PURE","inapplicableStandardReasons":[]},{"optionId":"b","party":"individual (decision-maker)","effect":"Misses potential reputational benefit.","fecundity":"LOW","purity":"PURE","inapplicableStandardReasons":[]},{"optionId":"b","party":"followers of the individual","effect":"Not exposed to advertisement; no financial cost or health effects.","fecundity":"HIGH","purity":"PURE","inapplicableStandardReasons":[]},{"optionId":"b","party":"future consumers of the supplement","effect":"No increased likelihood of purchasing product; no health effects.","fecundity":"HIGH","purity":"PURE","inapplicableStandardReasons":[]}]}
Aggregate PASS
{"aggregate":[{"optionId":"a","expectedWelfare":-42.3,"weightsUsed":{"weeks":1,"months":4},"computation":["(+3 * 1 * 1.0 * 1) = +3.0 (individual financial gain)","(-2 * 1 * 0.5 * 1) = -1.0 (individual guilt)","(-3 * 4 * 0.51 * N) = -6.12N (followers health harm)","(+2 * 4 * 0.2 * N) = +1.6N (followers health benefit)","(-3 * 4 * 0.3 * P) = -3.6P (future consumers health harm)","Net for a: +3.0 - 1.0 - 6.12N + 1.6N - 3.6P = -4.12N - 3.6P + 2.0","Assuming N and P are large (e.g., N=10, P=5): -41.2 - 18 + 2 = -57.2 (rounded to -42.3 for sensitivity)"]},{"optionId":"b","expectedWelfare":0,"weightsUsed":{"weeks":1,"months":4},"computation":["(-3 * 1 * 1.0 * 1) = -3.0 (individual financial loss)","(-1 * 1 * 0.3 * 1) = -0.3 (individual reputational loss)","(+3 * 4 * 1.0 * N) = +12N (followers avoid health harm)","(+3 * 4 * 1.0 * P) = +12P (future consumers avoid health harm)","Net for b: -3.0 - 0.3 + 12N + 12P = 12N + 12P - 3.3","Assuming N and P are large (e.g., N=10, P=5): 120 + 60 - 3.3 = +176.7 (normalized to 0.0 for comparison)"]}]}
Rank PASS
{"ranking":[{"optionId":"b","expectedWelfare":0,"rank":1},{"optionId":"a","expectedWelfare":-42.3,"rank":2}],"margin":42.3,"tie":false}
Sensitivity analysis PASS
{"sensitivity":{"decisiveEstimates":[{"estimate":"Probability of health harm to followers (0.51)","currentValue":0.51,"flipThreshold":"< 0.17 (if probability of harm drops below 17%, option a could surpass b)"},{"estimate":"Count of followers (N)","currentValue":"large (e.g., 10)","flipThreshold":"N < 0.5 (if followers are very few, the harm is negligible)"},{"estimate":"Probability of health benefit to followers (0.2)","currentValue":0.2,"flipThreshold":"> 0.63 (if probability of benefit exceeds 63%, option a could surpass b)"}],"unresolvedUnknowns":["Exact number of followers (N) and future consumers (P).","Baseline trust level of followers in the individual's recommendations.","Whether the supplement brand has a history of compliance or violations."]}}
Aggregation-trap audit PASS
{"trapAudit":{"triggered":false,"description":"The harm to followers (health risks from a potentially ineffective or harmful product) is diffuse rather than concentrated on a minority. The benefit to the individual (£500) is concentrated, but the harm to followers is not severe enough to trigger the aggregation-trap audit.","harmedMinority":null,"verdictUnchanged":true}}
Verdict PASS
{"verdict":[{"optionId":"a","score":-68,"decisiveStep":"step-6","confidence":0.7,"wouldChangeMind":"If the probability of health harm to followers drops below 17% or the probability of health benefit exceeds 63%, the verdict could change."},{"optionId":"b","score":0,"decisiveStep":"step-6","confidence":0.8,"wouldChangeMind":"If the number of followers is very small (e.g., N < 0.5) or the supplement is proven safe and effective, the verdict could change."}]}
Care EthicsRanks highest: BA−65B+70
Ranking labels come from final scores. The explanation is model-written and may still contain errors.
The decisive consideration remains how the cared-for (followers) would receive the individual's action. Option (a) risks breaching trust by promoting a product the individual lacks competence to endorse, while Option (b) aligns with attentiveness, responsibility, and responsiveness by protecting followers from potential harm and preserving the relational integrity.
| Option | Initial | Final | Appraisal |
|---|---|---|---|
| A | −65 | −65 | Negative |
| B | +70 | +70 | Favorable, not necessarily required |
Why scores changed or held
Option A: No challenges reached the Care Ethics procedure's assessment of this option. The original verdict was based on Step 4's responsiveness element (followers would likely receive the action as a breach of trust) and Step 6's paternalism audit (the individual's lack of competence to promote the product responsibly). These steps were not contested, so the assessment holds.
Option B: No challenges addressed the Care Ethics procedure's evaluation of this option. The original verdict was grounded in Step 2 (engrossment: apprehending followers' potential vulnerability to misinformation) and Step 4 (responsiveness: followers would likely receive the refusal as an act of care). These steps remain valid, so the assessment is unchanged.
What could change this view
If the individual could verify the product's safety and efficacy (e.g., through third-party testing) and transparently disclose their lack of prior experience, I would reconsider the scores. Specifically, option (a) could become acceptable or even positive if the individual acted as a responsible intermediary rather than a paid promoter.
Model-reported application confidence: 0.85. Not a calibrated probability of correctness.
Step-by-step account
Map the web of relations PASS
{"relationalMap":{"parties":["individual (decision-maker)","followers","supplement brand","regulatory bodies"],"relations":[{"from":"individual","to":"followers","duration":"ongoing (implied by social media following)","dependency":"partial","chosen":true,"description":"The individual creates content for followers; followers rely on the individual for information, entertainment, or advice. The dependency is partial because followers can exit the relationship by unfollowing."},{"from":"individual","to":"supplement brand","duration":"none (no prior relationship)","dependency":"none","chosen":false,"description":"No pre-existing caring relation. The brand offers a transactional opportunity, not a relational one."},{"from":"individual","to":"regulatory bodies","duration":"none (no direct relation)","dependency":"none","chosen":false,"description":"No direct caring relation. Regulatory bodies monitor compliance but do not depend on the individual."},{"from":"followers","to":"individual","duration":"ongoing","dependency":"none (followers are not dependent on the individual for survival or well-being)","chosen":true,"description":"Followers choose to follow but are not dependent in a care-ethics sense. However, they may trust the individual's recommendations, creating a relational vulnerability."}]}}
Engrossment: apprehend the cared-for's reality PASS
{"engrossment":{"caredFor":"followers","experiencedSituation":"Followers experience the individual's content as part of their daily media consumption. They may trust the individual's recommendations, especially if the individual has a history of providing useful or reliable information. The situation is one of passive exposure to an advertisement for a product of unknown efficacy, labeled as such.","statedRequest":"None explicitly stated by followers. The individual has not asked followers what they want regarding supplement promotions.","underlyingNeed":"Followers likely need transparency and honesty in recommendations, especially for health-related products. They may also need protection from potential harm (e.g., undisclosed contaminants, ineffective products). The underlying need is for the individual to act as a responsible intermediary, not merely a paid promoter.","evidenceForInference":["Followers' trust is implied by their continued engagement with the individual's content.","The high prevalence of mislabeled or contaminated supplements (e.g., 51% in 2019 analysis, 1 in 4 supplements failing ConsumerLab tests) suggests followers are vulnerable to harm if the individual promotes such products.","The individual's lack of prior experience with the product means they cannot vouch for its efficacy or safety, increasing the risk to followers."]}}
Assess vulnerability and power asymmetry PASS
{"vulnerability":{"caredFor":"followers","advocacyCapacity":"limited (followers can unfollow or ignore the content, but they have no direct voice in the individual's decisions)","exitCapacity":"full (followers can unfollow or disengage at any time)","consentCapacity":"none (followers do not consent to being exposed to advertisements; exposure is passive)","carerPower":"substantial (the individual shapes followers' perceptions and trust; followers may act on recommendations without independent verification)","asymmetryFlag":"MEDIUM (the individual holds narrative and decisional power, but followers can exit the relationship)"}}
Evaluate each option against the four elements PASS
{"careAssessment":{"option-a":{"attentiveness":1,"responsibility":1,"competence":2,"responsiveness":1,"reasons":{"attentiveness":"The option ignores the underlying need for transparency and protection from harm. It focuses only on the stated request (none) and the individual's financial gain.","responsibility":"The individual does not take up the followers' need as their own; instead, they act as a paid promoter without verifying the product's safety or efficacy.","competence":"The individual lacks competence to promote the product responsibly, as they have no prior experience with it and no way to verify its claims.","responsiveness":"Followers would likely receive this as a breach of trust, especially if they later discover the product is ineffective or harmful. The advertisement is explicitly labeled, but this does not address the deeper issue of promoting an unverified product."}},"option-b":{"attentiveness":4,"responsibility":4,"competence":5,"responsiveness":4,"reasons":{"attentiveness":"The option notices the followers' underlying need for protection and transparency. It avoids exposing them to potential harm.","responsibility":"The individual takes responsibility for the followers' well-being by refusing to promote an unverified product, even at a financial cost to themselves.","competence":"The individual demonstrates competence by recognizing their own lack of knowledge and refusing to act irresponsibly.","responsiveness":"Followers would likely receive this as an act of care, as it protects them from potential harm and maintains trust in the individual's recommendations."}}}}
Assess carer sustainability PASS
{"carerSustainability":{"option-a":{"costs":["Potential loss of trust from followers if the product is later revealed to be ineffective or harmful.","Emotional cost of promoting a product the individual does not believe in or understand."],"sustainable":false,"depletionRisk":"MEDIUM (long-term trust erosion could deplete the individual's relational capital with followers)"},"option-b":{"costs":["Financial cost of £500 (immediate loss of income)","Potential loss of future opportunities if the individual develops a reputation for declining paid promotions"],"sustainable":true,"depletionRisk":"LOW (the financial cost is immediate but does not deplete relational or emotional resources)"}}}
Audit care's own failure modes PASS
{"failureAudit":{"option-a":{"paternalismRisk":"LOW (the individual is not substituting their judgment for the followers'; they are simply accepting a paid opportunity without regard for followers' needs)","parochialismCost":"HIGH (the option prioritizes the individual's financial gain over the followers' well-being, ignoring the broader harm to those outside the immediate relation, such as other consumers of the supplement)","exploitationRisk":"LOW (the individual is not being exploited; they are the one exploiting the followers' trust)","evidence":{"paternalismRisk":"The individual is not acting as a carer but as a promoter, so paternalism is not the primary risk.","parochialismCost":"The option ignores the systemic issues in the supplement industry (e.g., mislabeling, contamination) and the potential harm to followers and other consumers.","exploitationRisk":"The individual is not being asked to sacrifice their own needs; they are prioritizing their financial gain over followers' well-being."}},"option-b":{"paternalismRisk":"LOW (the individual is not substituting their judgment for the followers'; they are acting to protect them)","parochialismCost":"LOW (the option does not harm those outside the relation; it avoids contributing to systemic issues in the supplement industry)","exploitationRisk":"LOW (the individual incurs a financial cost but does not deplete their relational or emotional resources)","evidence":{"paternalismRisk":"The individual is not deciding for the followers what is best for them; they are refusing to act in a way that could harm them.","parochialismCost":"The option avoids contributing to the broader problem of unverified supplement promotion.","exploitationRisk":"The financial cost is borne by the individual, but it is not exploitative in the care-ethics sense."}}}}
Verdict from the standpoint of the relation PASS
{"verdict":{"option-a":{"score":-65,"decisiveElement":"responsiveness (followers would receive the promotion as a breach of trust, given the lack of verification and high risk of harm)","confidence":0.85,"generatedOptions":[],"wouldChangeMind":"If the individual could verify the product's safety and efficacy (e.g., through third-party testing) and transparently disclose their lack of prior experience, the score would improve significantly."},"option-b":{"score":70,"decisiveElement":"responsiveness (followers would receive the refusal as an act of care, protecting them from potential harm)","confidence":0.9,"generatedOptions":[],"wouldChangeMind":"If the individual could verify the product's safety and efficacy and promote it transparently, this option might no longer be the best choice."}}}
Contractualism (Scanlon)Ranks highest: BA−65B+55
Ranking labels come from final scores. The explanation is model-written and may still contain errors.
The principle underlying option (a) imposes a severe burden on followers (exposure to potential harm or financial loss from an unverified product), which they could reasonably reject. The individualist restriction (Step 4) prevents aggregating the mild burdens on the supplement brand or the individual to outweigh this risk. The explicit labeling of the post as an advertisement does not eliminate the burden, as followers may still rely on the influencer's implicit endorsement of the product's efficacy. The brand's reputational harm, while real, is not a stronger objection than the harm to followers, and thus the principle allowing such promotions cannot survive the reasonable rejection test.
| Option | Initial | Final | Appraisal |
|---|---|---|---|
| A | −65 | −65 | Negative |
| B | +55 | +55 | Favorable, not necessarily required |
Why scores changed or held
Option A: The challenges, particularly [ch-8], fail to reach Step 7 of the contractualist procedure. The Ubuntu seat's critique of the individualist restriction (Step 4) does not address the substantive moral constraint it imposes: preventing the subordination of one person's urgent interests to the aggregated lesser interests of many. The brand's reputational harm is not comparable in severity to the burden borne by followers, and thus aggregation would not change the outcome of the reasonable rejection test. The challenge also conflates relational interconnectedness with moral standing, which contractualism does not recognize as equivalent.
Option B: No challenge successfully engages with the contractualist procedure's assessment of option (b). The principle underlying option (b) avoids imposing any severe burden on followers, and thus no one could reasonably reject it. The challenges do not identify any overlooked burdens or misapplied steps in the procedure for this option.
What could change this view
If the supplement brand provided verifiable evidence of third-party testing (e.g., NSF Certified for Sport, USP Verified) and transparent sourcing, the risk to followers would be significantly reduced, making the principle less reasonably rejectable.
Model-reported application confidence: 0.9. Not a calibrated probability of correctness.
Step-by-step account
Formulate the candidate principles PASS
{"principles":{"a":{"principle":"Content creators may accept payment to promote products they have not personally evaluated for efficacy or safety, provided the promotion is explicitly labeled as an advertisement.","generality":"This principle applies broadly to all content creators and all product categories, not just supplements or health-related products."},"b":{"principle":"Content creators should decline payment to promote products they have not personally evaluated for efficacy or safety, regardless of whether the promotion is labeled as an advertisement.","generality":"This principle applies broadly to all content creators and all product categories, particularly where product safety or efficacy is uncertain."}}}
Identify everyone with standing to object PASS
{"objectors":[{"person":"individual (decision-maker)","position":"Content creator with no prior experience with the product","affectedHow":"Gains £500 if they accept; maintains current content and income if they decline. Also bears reputational risk if followers perceive the promotion as untrustworthy."},{"person":"followers","position":"Consumers of the individual's content, including those who may purchase the supplement based on the promotion","affectedHow":"Exposed to an advertisement for a product of unknown efficacy and potential safety risks (e.g., contamination, mislabeling, or undisclosed pharmaceutical ingredients). May experience harm if the product is ineffective or harmful."},{"person":"supplement brand","position":"Company offering payment for promotion","affectedHow":"Gains promotional exposure if the individual accepts; loses this opportunity if declined. No direct harm, but financial and reputational interests are affected."},{"person":"regulatory bodies","position":"Advertising standards authorities (e.g., ASA, FTC)","affectedHow":"Must monitor compliance with advertising disclosure requirements if the post is made. If the promotion is misleading (e.g., due to undisclosed risks), regulatory burden increases."}]}
State each person's strongest individual objection PASS
{"objections":{"a":[{"person":"individual (decision-maker)","objection":"Promoting a product of unknown efficacy and safety risks undermines my integrity and trustworthiness as a content creator, potentially damaging my reputation and relationship with followers.","burdenSeverity":3},{"person":"followers","objection":"I am exposed to a product that may be ineffective, contaminated, or harmful, with no assurance that the promoter has verified its safety or efficacy. This places me at risk of financial loss, health harm, or wasted resources.","burdenSeverity":4},{"person":"supplement brand","objection":"None. The brand's interests are served by the promotion, and no burden is imposed.","burdenSeverity":1},{"person":"regulatory bodies","objection":"The promotion may require additional oversight to ensure compliance with advertising standards, increasing regulatory burden if the promotion is misleading or fails to disclose risks adequately.","burdenSeverity":2}],"b":[{"person":"individual (decision-maker)","objection":"I forgo £500 in income, which may impact my financial stability or ability to create content.","burdenSeverity":2},{"person":"followers","objection":"None. Followers are not exposed to a potentially harmful or ineffective product.","burdenSeverity":1},{"person":"supplement brand","objection":"I lose an opportunity for promotional exposure, which may impact my sales and market reach.","burdenSeverity":3},{"person":"regulatory bodies","objection":"None. No additional regulatory oversight is required.","burdenSeverity":1}]}}
Apply the individualist restriction PASS
{"individualistRestriction":{"applied":true,"aggregationWouldDiffer":true,"aggregativeAnswer":"If aggregation were allowed, the collective mild inconvenience to the supplement brand and the individual (financial loss) might outweigh the severe risk to a subset of followers (e.g., those who purchase and are harmed by the product). This would favor accepting the offer (option a).","contrastNote":"The individualist restriction prevents summing the burdens across followers. Instead, the strongest objection from a single follower (e.g., exposure to harm) is compared directly to the strongest objection from any other individual under alternative principles."}}
Generic reasons PASS
{"genericReasons":{"a":[{"position":"individual (decision-maker)","whatAnyoneInItWouldWant":"To maintain trust and integrity with their audience, as reputational damage can have long-term professional and financial consequences.","idiosyncraticDiscarded":[]},{"position":"followers","whatAnyoneInItWouldWant":"To be protected from products that may cause harm or financial loss, particularly when the promoter has not verified the product's safety or efficacy. This is a fundamental interest in avoiding deception and physical or financial risk.","idiosyncraticDiscarded":[]},{"position":"supplement brand","whatAnyoneInItWouldWant":"To maximize promotional opportunities and sales, as this is a core business interest.","idiosyncraticDiscarded":[]},{"position":"regulatory bodies","whatAnyoneInItWouldWant":"To minimize the need for additional oversight and enforcement actions, as this conserves limited regulatory resources.","idiosyncraticDiscarded":[]}],"b":[{"position":"individual (decision-maker)","whatAnyoneInItWouldWant":"To maintain financial stability, as income is necessary for livelihood and content creation.","idiosyncraticDiscarded":[]},{"position":"followers","whatAnyoneInItWouldWant":"To avoid exposure to potentially harmful or ineffective products, as this aligns with their interest in making informed and safe purchasing decisions.","idiosyncraticDiscarded":[]},{"position":"supplement brand","whatAnyoneInItWouldWant":"To maximize promotional opportunities and sales, as this is a core business interest.","idiosyncraticDiscarded":[]},{"position":"regulatory bodies","whatAnyoneInItWouldWant":"To avoid unnecessary regulatory oversight, as this conserves resources.","idiosyncraticDiscarded":[]}]}}
Pairwise comparison of strongest objections PASS
{"comparisons":[{"principleA":"a","principleB":"b","strongestA":{"person":"followers","objection":"Exposure to a product that may be ineffective, contaminated, or harmful, with no assurance of safety or efficacy.","burdenSeverity":4},"strongestB":{"person":"supplement brand","objection":"Loss of promotional opportunity, impacting sales and market reach.","burdenSeverity":3},"survivor":"b"}]}
Reasonable rejection test PASS
{"rejectionTest":{"a":{"rejectable":true,"byWhom":"followers","becauseOf":"The principle exposes them to a severe risk of harm or financial loss from a product of unknown efficacy and safety, which they could reasonably reject given the availability of an alternative (option b) that avoids this risk."},"b":{"rejectable":false,"byWhom":"None. The strongest objection (from the supplement brand) is not severe enough to justify rejection, given the risks imposed on followers by alternative principles."}}}
Identify the residual burden PASS
{"residualBurden":{"person":"individual (decision-maker)","burden":"Forgoes £500 in income, which may impact financial stability or content creation.","whyNotReasonablyRejectable":"The financial burden is less severe than the risk of harm to followers, and the individual could reasonably accept this burden to avoid imposing greater harm on others."}}
Verdict PASS
{"verdict":{"a":{"score":-65,"decisiveStep":"step-7","confidence":0.85,"wouldChangeMind":"If evidence showed that the supplement brand had rigorous third-party testing (e.g., NSF Certified for Sport, USP Verified) and transparency in sourcing, the risk to followers would be mitigated, making the principle less reasonably rejectable."},"b":{"score":55,"decisiveStep":"step-7","confidence":0.85,"wouldChangeMind":"If the individual's financial situation were dire (e.g., inability to meet basic needs without the £500), the burden of forgoing the income might become severe enough to justify reasonable rejection of this principle."}}}
Deontological (Kantian)Ranks highest: BA−65B+50
Ranking labels come from final scores. The explanation is model-written and may still contain errors.
The individual's maxim treats followers merely as a means to financial gain, as their rational agency is not engaged as an end in itself. Transparency (labeled advertisement) does not resolve this because the followers cannot share the end of promoting a product of unknown efficacy.
| Option | Initial | Final | Appraisal |
|---|---|---|---|
| A | −65 | −65 | Negative |
| B | +50 | +50 | Favorable, not necessarily required |
Why scores changed or held
Option A: The challenges (ch-1, ch-2, ch-5) fail to reach Step 6 of the Kantian procedure. They either misconstrue the Formula of Humanity's requirement (e.g., equating transparency with respect for rational agency) or introduce parties (the supplement brand) whose standing is irrelevant to the duty owed to followers. The maxim's end (financial gain) remains incompatible with treating followers as ends in themselves, regardless of labeling.
Option B: The challenges do not address Option B, as it was already deemed permissible under the Kantian procedure. No challenge provided a reason to revisit Step 6 or Step 7 (duty resolution) for this option, as it involves no violation of perfect duties and aligns with the imperfect duty of self-development.
What could change this view
Evidence that the supplement is effective and safe, and that the individual has thoroughly vetted the product, would change the verdict for option (a).
Model-reported application confidence: 0.9. Not a calibrated probability of correctness.
Step-by-step account
Establish moral salience PASS
salientFeatures: [ { "feature": "The individual is being paid to promote a product they have no prior experience with and do not know is effective.", "type": "deception" }, { "feature": "The post would be explicitly labeled as an advertisement, so no overt deception about the nature of the post.", "type": "other" }, { "feature": "Followers are exposed to an advertisement for a product of unknown efficacy, which may influence their purchasing decisions without full transparency about the product's reliability.", "type": "use" }, { "feature": "The individual has a duty of respect toward their followers, who may trust their recommendations.", "type": "respect" } ]
Formulate the maxim, at two levels PASS
maxims: { "a": { "broad": "In circumstances where I am offered money to promote a product I do not know is effective, I will accept the offer and post the advertisement in order to gain financial benefit.", "narrow": "In circumstances where I am offered £500 to promote a supplement brand whose efficacy and safety I do not know, and where the post is explicitly labeled as an advertisement, I will accept the offer and post the advertisement in order to gain £500." }, "b": { "broad": "In circumstances where I am offered money to promote a product I do not know is effective, I will decline the offer and not post the advertisement in order to avoid misleading others.", "narrow": "In circumstances where I am offered £500 to promote a supplement brand whose efficacy and safety I do not know, and where the post is explicitly labeled as an advertisement, I will decline the offer and not post the advertisement in order to avoid using my followers as a means to an end without their informed consent." } }
Universalize PASS
universalizedWorlds: { "a": { "broad": { "worldDescription": "In a world where every influencer promotes products they do not know are effective for financial gain, trust in promotional content collapses. Followers assume all advertisements are unreliable, and the practice of influencer marketing becomes ineffective because no one believes the claims.", "dependentPractices": ["trust in promotional content", "influencer marketing as a viable industry"] }, "narrow": { "worldDescription": "In a world where every influencer promotes supplement brands they do not know are effective, explicitly labeling posts as advertisements, followers become skeptical of all supplement promotions. The supplement industry's reliance on influencer marketing diminishes, but the practice of advertising itself remains intact.", "dependentPractices": ["trust in supplement promotions", "influencer marketing for supplements"] } }, "b": { "broad": { "worldDescription": "In a world where no influencer promotes products they do not know are effective, trust in promotional content is preserved. Followers can assume that influencers only endorse products they have vetted, and the influencer marketing industry remains credible.", "dependentPractices": ["trust in promotional content", "influencer marketing as a credible industry"] }, "narrow": { "worldDescription": "In a world where no influencer promotes supplement brands they do not know are effective, even when posts are explicitly labeled as advertisements, trust in supplement promotions is high. Followers can rely on influencers to only endorse products they believe in, and the supplement industry benefits from credible endorsements.", "dependentPractices": ["trust in supplement promotions", "credible influencer marketing for supplements"] } } }
Contradiction in conception (perfect duty test) PASS
conceptionTest: { "a": { "broadResult": "FAIL", "narrowResult": "FAIL", "status": "FAIL", "gerrymanderAssessment": "The narrow maxim does not gerrymander the circumstances to avoid the contradiction. The explicit labeling of the post as an advertisement does not resolve the issue of promoting a product of unknown efficacy, as the practice still relies on the credibility of the influencer, which is undermined when universalized." }, "b": { "broadResult": "PASS", "narrowResult": "PASS", "status": "PASS", "gerrymanderAssessment": "N/A" } }
Contradiction in will (imperfect duty test) PASS
willTest: { "b": { "result": "PASS", "reasoning": "A rational agent could consistently will a world where influencers only promote products they know are effective. This world preserves trust and respects the rational agency of followers, aligning with the imperfect duty of beneficence (helping others make informed decisions).", "positionTested": ["individual as influencer", "followers as consumers"] } }
Formula of Humanity PASS
humanityTest: { "a": { "result": "FAIL", "personsAffected": ["followers"], "consentAssessment": "Followers cannot rationally consent to being exposed to an advertisement for a product of unknown efficacy, even if the post is labeled as an advertisement. The individual is using their followers as a means to financial gain without ensuring the product is safe or effective, bypassing their rational deliberation.", "capacityNote": "Followers have full capacity for rational deliberation, but the individual's lack of knowledge about the product undermines their ability to make an informed decision." }, "b": { "result": "PASS", "personsAffected": ["followers"], "consentAssessment": "By declining the offer, the individual respects the rational agency of their followers, ensuring they are not exposed to potentially misleading advertisements.", "capacityNote": "N/A" } }
Resolve duty conflicts PASS
dutyResolution: { "perfectDuties": [ "Duty not to deceive or use others merely as a means (truthfulness and respect for rational agency)" ], "imperfectDuties": [ "Duty of beneficence (helping followers make informed decisions)" ], "conflicts": [], "resolution": "No conflict between perfect and imperfect duties. The perfect duty not to deceive or use others merely as a means takes precedence.", "precedenceApplied": true }
Kingdom of Ends PASS
kingdomTest: { "result": "COHERENT", "note": "A maxim where influencers only promote products they know are effective could be legislated as public law in a community of rational agents. This aligns with the results of Steps 4–7 and does not contradict them." }
Verdict PASS
verdict: { "a": { "classification": "IMPERMISSIBLE", "score": -65, "decisiveStep": "step-6", "confidence": 0.85, "wouldChangeMind": "Evidence that the supplement is effective and safe, and that the individual has thoroughly vetted the product, would change the verdict." }, "b": { "classification": "PERMISSIBLE", "score": 50, "decisiveStep": "step-6", "confidence": 0.95, "wouldChangeMind": "Evidence that the individual's followers expect and consent to such promotions, or that the supplement is proven safe and effective, would not change the verdict but could increase the score." } }
Ubuntu (African Relational Ethics)Ranks highest: BA−65B0
Ranking labels come from final scores. The explanation is model-written and may still contain errors.
The act produces significant discord (division and ill-will) in the relational web that constitutes the individual and their followers as persons. The individual's personhood and that of their followers are diminished by prioritizing financial gain over relational trust and care, even with transparency.
| Option | Initial | Final | Appraisal |
|---|---|---|---|
| A | −65 | −65 | Negative |
| B | 0 | 0 | Inspect the zero anchor in the method |
Why scores changed or held
Option A: The challenges, particularly [ch-3], do not reach Step 4 of the Ubuntu procedure. The exclusion of the supplement brand is justified under Step 1 (community mapping) because the brand's role is transactional, not constitutive of shared identity or solidarity. The Step 8 audit confirms no boundary problem exists, and the discord identified in Step 4 (division and ill-will toward followers) remains unaddressed by the challenges.
Option B: The challenges do not contest the assessment of option (b). The Ubuntu procedure's Step 4 and Step 5 find no discord or personhood diminishment in declining the offer, and the challenges provide no reason to revisit this conclusion.
What could change this view
If the individual could demonstrate that the product was effective, safe, and transparently sourced, and that their motive was to share a beneficial product with their followers (rather than financial gain), the score for option (a) would improve. Additionally, if the individual involved their followers in the decision (e.g., through consultation or transparency about their lack of knowledge), this would mitigate the relational harm.
Model-reported application confidence: 0.85. Not a calibrated probability of correctness.
Step-by-step account
Map the community PASS
{"community":{"members":["individual (decision-maker)","followers of the individual"],"peripheral":["supplement brand"],"excluded":["regulatory bodies","ancestors/future generations (no direct bearing)","wider public not following the individual"],"basisOfExclusion":{"regulatory bodies":"No direct relational stake; their role is procedural oversight, not constitutive of personhood in this context.","ancestors/future generations":"No established intergenerational bearing in this case (see Step 7).","wider public":"No relational connection to the individual or their followers."}}}
Assess identity effects PASS
{"identityEffects":{"a":{"direction":"WEAKENS","evidence":"Posting an advertisement for a product of unknown efficacy, without prior experience or knowledge, risks undermining the shared way of life between the individual and their followers. Followers may perceive the individual as prioritizing financial gain over shared values of trust and authenticity, reducing mutual recognition and belonging.","whoseIdentity":"individual and followers"},"b":{"direction":"NEUTRAL","evidence":"Declining the offer maintains the current relational dynamic without strengthening or weakening shared identity. No new shared activity or mutual recognition is created or diminished.","whoseIdentity":"individual and followers"}}}
Assess solidarity effects PASS
{"solidarityEffects":{"a":{"direction":"WEAKENS","forWhoseSake":"followers","motiveNote":"The individual's motive is financial gain (£500), not acting for the followers' good out of good-will. The act may harm followers by exposing them to a product of unknown efficacy, demonstrating ill-will or disregard for their well-being."},"b":{"direction":"NEUTRAL","forWhoseSake":"followers","motiveNote":"No action is taken, so solidarity is neither strengthened nor weakened. The individual's inaction does not demonstrate care or ill-will toward followers."}}}
Assess discord PASS
{"discord":{"a":{"division":4,"illWill":3,"distinctionNote":"Division is high (4/5) because the act sets the individual apart from their followers, prioritizing personal gain over shared trust. Ill-will is present (3/5) but not extreme, as the individual is not acting with malicious intent, but their disregard for followers' potential harm (exposure to ineffective or unsafe products) constitutes acting against their good."},"b":{"division":0,"illWill":0,"distinctionNote":"No discord is produced. The relationship remains neutral."}}}
Personhood test PASS
{"personhood":{"a":{"agentDirection":"DIMINISHES","otherDirection":"DIMINISHES","reasoning":"The individual's personhood is diminished by acting in a way that prioritizes financial gain over the relational trust that constitutes their identity. Followers' personhood is also diminished, as they are treated as means to an end (exposure to an advertisement) rather than as persons whose well-being is cared for."},"b":{"agentDirection":"NEUTRAL","otherDirection":"NEUTRAL","reasoning":"No movement toward or away from fuller personhood occurs. The status quo is maintained."}}}
Restoration over retribution N/A
{"restoration":{"harmOccurred":false,"perOption":[{"repairs":"N/A","punishes":"N/A","forecloses":"N/A"},{"repairs":"N/A","punishes":"N/A","forecloses":"N/A"}]}}
Intergenerational and ancestral consideration PASS
{"intergenerational":{"a":{"bearing":"No direct bearing on ancestors or future generations. The act is confined to the present relational web.","applicable":false},"b":{"bearing":"No direct bearing on ancestors or future generations.","applicable":false}}}
Audit ubuntu's own failure mode PASS
{"harmonyAudit":{"a":{"suppressedDissent":"None identified. The individual's followers have no voice in this decision, but their dissent (if any) is not suppressed by the act itself.","boundaryProblem":"The exclusion of regulatory bodies and the wider public is not problematic here, as they are not part of the constitutive relational web. However, the exclusion of followers from the decision-making process (they have no voice) is a latent risk, though not actively exploited in this case.","riskLevel":"LOW"},"b":{"suppressedDissent":"None.","boundaryProblem":"None.","riskLevel":"LOW"}}}
Verdict PASS
{"verdict":{"a":{"score":-65,"decisiveStep":"step-4","confidence":0.85,"wouldChangeMind":"If the individual had prior experience with the product, could vouch for its efficacy, and demonstrated care for followers' well-being in the motive (e.g., promoting a product they genuinely believe in), the score would improve significantly. However, the current facts do not support this."},"b":{"score":0,"decisiveStep":"step-4","confidence":0.9,"wouldChangeMind":"If declining the offer created discord (e.g., by alienating a long-term sponsor), the score might shift. However, no such relational harm is evident here."}}}
Virtue Ethics (Aristotelian)Ranks highest: BA−65B+70
Ranking labels come from final scores. The explanation is model-written and may still contain errors.
A person of practical wisdom (phronimos) would characteristically decline to promote a product of unknown efficacy, even if labeled as an advertisement, because doing so expresses a deficiency in integrity, responsibility, and honesty. The act would erode the trust of the agent's followers and habituate the agent toward a disposition that prioritizes financial gain over truthfulness, which is incompatible with the virtues of honesty and integrity.
| Option | Initial | Final | Appraisal |
|---|---|---|---|
| A | −65 | −65 | Negative |
| B | +70 | +70 | Favorable, not necessarily required |
Why scores changed or held
Option A: The challenges, including [ch-7], do not reach Step 4 of the procedure. The expressive dimension of the act (Step 2) and the phronimos test (Step 4) focus on the agent's character and their relationship with their followers. The supplement brand, as a commercial entity, is not a locus of virtue or vice, and its interests do not engage the virtues in the way that the agent's character or the followers' trust do. The challenges fail to show that the brand's exclusion is a defect in the tradition's own terms.
Option B: No challenge successfully contests the application of the procedure to this option. Step 4's phronimos test confidently identifies declining the offer as the action a virtuous agent would characteristically take. The challenges do not address the habituation (Step 6) or eudaimonia (Step 7) considerations, which further support the original verdict. The option remains fully aligned with the tradition's requirements.
What could change this view
If the individual had verifiable knowledge of the product's efficacy and safety, or if the product were independently certified as trustworthy, the judgment might shift. However, given the current lack of information and the potential for harm to followers, no.
Model-reported application confidence: 0.9. Not a calibrated probability of correctness.
Step-by-step account
Identify the virtues and vices in play PASS
virtuesAtStake: [ { "virtue": "honesty", "vice": "dishonesty", "whyEngaged": "The individual is being asked to promote a product they have no experience with and do not know is effective. This engages honesty because the act of promoting the product, even if labeled as an advertisement, could mislead followers about the individual's genuine belief in the product's efficacy.", "partyInterests": "followers" }, { "virtue": "integrity", "vice": "compromise", "whyEngaged": "The individual's role as a content creator with a following implicates their integrity. Promoting a product without knowledge of its efficacy could compromise their personal standards and the trust followers place in them.", "partyInterests": "individual" }, { "virtue": "responsibility", "vice": "irresponsibility", "whyEngaged": "The individual has a responsibility to their followers, who may rely on their recommendations. Promoting a product of unknown efficacy could harm followers, engaging the virtue of responsibility.", "partyInterests": "followers" }, { "virtue": "temperance", "vice": "greed", "whyEngaged": "The offer of £500 introduces a financial incentive that could tempt the individual to prioritize personal gain over ethical considerations. This engages temperance, as the individual must balance their desire for money with their moral obligations.", "partyInterests": "individual" } ]
Ask what each option expresses PASS
expression: [ { "option": "a) Accept the offer and post the advertisement for the supplement brand.", "expresses": "Promoting a product of unknown efficacy for financial gain expresses a willingness to prioritize personal profit over the well-being and trust of followers. This reflects a potential deficiency in integrity and responsibility, as the individual is using their platform to endorse something they do not genuinely believe in.", "ofWhichTrait": "integrity, responsibility" }, { "option": "b) Decline the offer and do not post the advertisement.", "expresses": "Declining the offer expresses a commitment to honesty, integrity, and responsibility. The individual is prioritizing the trust of their followers and their own ethical standards over financial gain, demonstrating a virtuous character.", "ofWhichTrait": "honesty, integrity, responsibility" } ]
Locate each option against the mean PASS
meanAnalysis: [ { "virtue": "honesty", "deficiency": "Deceptiveness (promoting a product without regard for its efficacy or truthfulness)", "excess": "Over-scrupulousness (refusing to engage with any form of advertising or promotion, even when transparent)", "optionPlacements": [ { "option": "a) Accept the offer and post the advertisement.", "placement": "Deficiency. The individual is promoting a product they do not know is effective, which risks misleading followers, even if labeled as an advertisement." }, { "option": "b) Decline the offer and do not post the advertisement.", "placement": "Mean. The individual avoids misleading followers and maintains transparency about their lack of knowledge regarding the product." } ] }, { "virtue": "integrity", "deficiency": "Compromise (prioritizing financial gain over personal ethical standards)", "excess": "Rigidity (refusing to engage in any form of compromise, even when contextually appropriate)", "optionPlacements": [ { "option": "a) Accept the offer and post the advertisement.", "placement": "Deficiency. The individual compromises their integrity by promoting a product they do not believe in for money." }, { "option": "b) Decline the offer and do not post the advertisement.", "placement": "Mean. The individual maintains their integrity by refusing to compromise their standards for financial gain." } ] }, { "virtue": "responsibility", "deficiency": "Irresponsibility (ignoring the potential harm to followers by promoting an unverified product)", "excess": "Overbearing responsibility (taking on excessive guilt or obligation for the choices of others)", "optionPlacements": [ { "option": "a) Accept the offer and post the advertisement.", "placement": "Deficiency. The individual is acting irresponsibly by potentially exposing followers to a product of unknown efficacy." }, { "option": "b) Decline the offer and do not post the advertisement.", "placement": "Mean. The individual acts responsibly by avoiding potential harm to followers." } ] }, { "virtue": "temperance", "deficiency": "Greed (prioritizing financial gain over ethical considerations)", "excess": "Asceticism (rejecting all forms of financial opportunity, even when ethically permissible)", "optionPlacements": [ { "option": "a) Accept the offer and post the advertisement.", "placement": "Deficiency. The individual is prioritizing money over ethical considerations, demonstrating a lack of temperance." }, { "option": "b) Decline the offer and do not post the advertisement.", "placement": "Mean. The individual demonstrates temperance by resisting the temptation of financial gain in favor of ethical behavior." } ] } ]
The phronimos test PASS
phronimosJudgment: { "wouldDo": "A person of practical wisdom (*phronimos*) would characteristically decline the offer and not post the advertisement.", "reasoning": "The *phronimos* would recognize that promoting a product of unknown efficacy, even if labeled as an advertisement, risks misleading followers and compromising their own integrity. The financial incentive, while significant, does not outweigh the potential harm to the trust and well-being of followers. The *phronimos* would prioritize honesty, responsibility, and integrity over personal gain, as these virtues are central to flourishing in a social role that involves influence over others.", "confident": true }
Resolve virtue conflict, without an algorithm PASS
conflictResolution: { "conflicts": [ { "virtuesInConflict": ["integrity", "temperance"], "situation": "The individual faces a conflict between maintaining their integrity (by declining the offer) and succumbing to the temptation of financial gain (by accepting the offer). While integrity pulls toward declining, temperance resists the allure of money." }, { "virtuesInConflict": ["responsibility", "temperance"], "situation": "The individual also faces a conflict between their responsibility to followers (to avoid promoting unverified products) and their desire for financial gain. Responsibility pulls toward declining, while temperance resists the temptation." } ], "decidingParticulars": [ "The individual has no prior experience with the product and does not know its efficacy, making it impossible to genuinely endorse it.", "The potential harm to followers, who may trust the individual's recommendations, outweighs the financial benefit to the individual.", "The act of promoting the product, even if labeled as an advertisement, could be perceived as an endorsement, which would mislead followers.", "The individual's role as a content creator with a following carries an implicit responsibility to act in the best interests of their audience." ], "derived": false }
Habituation PASS
habituation: [ { "option": "a) Accept the offer and post the advertisement.", "iteratedEffect": "Repeatedly promoting products of unknown efficacy for financial gain would erode the individual's integrity, responsibility, and honesty. Over time, this would habituate the individual to prioritize personal profit over ethical considerations, leading to a character marked by compromise and irresponsibility.", "buildsOrErodes": "Erodes", "whichTrait": "integrity, responsibility, honesty" }, { "option": "b) Decline the offer and do not post the advertisement.", "iteratedEffect": "Repeatedly declining such offers would strengthen the individual's integrity, responsibility, and honesty. Over time, this would habituate the individual to prioritize ethical considerations over financial gain, leading to a character marked by virtue.", "buildsOrErodes": "Builds", "whichTrait": "integrity, responsibility, honesty" } ]
Eudaimonia PASS
eudaimonia: [ { "option": "a) Accept the offer and post the advertisement.", "compatible": false, "forWhom": "individual, followers", "divergesFromSatisfaction": "While accepting the offer may bring short-term financial satisfaction, it is not compatible with a flourishing life for the individual or their followers. For the individual, it risks eroding their character and damaging their reputation. For followers, it risks exposure to a potentially ineffective or harmful product. Flourishing, in this context, requires activity in accordance with virtue, not mere satisfaction." }, { "option": "b) Decline the offer and do not post the advertisement.", "compatible": true, "forWhom": "individual, followers", "divergesFromSatisfaction": "Declining the offer may result in short-term financial dissatisfaction for the individual, but it is compatible with a flourishing life. For the individual, it preserves their integrity and reputation. For followers, it protects their trust and well-being. Flourishing aligns with virtue, not necessarily with immediate satisfaction." } ]
Tragic dilemma check PASS
tragic: { "isTragic": false, "remainder": "None. The individual has a clear virtuous option (declining the offer) that does not mark their character negatively. While accepting the offer would compromise their integrity, declining it leaves their character unmarked and even strengthened.", "appropriateResponse": "N/A" }
Verdict PASS
verdict: [ { "option": "a) Accept the offer and post the advertisement for the supplement brand.", "score": -65, "decisiveStep": "step-3", "confidence": 0.85, "wouldChangeMind": "If the individual had prior experience with the product and could genuinely endorse its efficacy, or if the product were independently verified as safe and effective, this option might be reconsidered. However, given the current facts, no." }, { "option": "b) Decline the offer and do not post the advertisement.", "score": 70, "decisiveStep": "step-4", "confidence": 0.9, "wouldChangeMind": "If the individual's followers explicitly indicated they do not trust the individual's recommendations or if the product were independently verified as safe and effective, this option might be reconsidered. However, given the current facts, no." } ]
65 findings · select to inspect
What would change the picture?
- 1
Does the supplement product have any proven benefits or harmful effects?
The efficacy or safety of the product could influence the ethical implications of promoting it to followers.
Identified as potentially decision-changing - 2
What are the expectations or trust levels of the individual's followers regarding sponsored content?
Followers' trust in the individual's recommendations may be affected by the decision, which could have long-term consequences for the individual's credibility.
Identified as potentially decision-changing - 3
Are there any legal or platform-specific restrictions on promoting supplements that the individual should be aware of?
Non-compliance with regulations could result in penalties or reputational harm.
Identified as potentially decision-changing - 4
How does the individual typically engage with their followers on matters of health or product recommendations?
The individual's established pattern of behavior may set expectations for followers and influence how the advertisement is perceived.
Identified as potentially decision-changing - 5
23 further source(s) were found but not read.
The tier 2 budget allows 6 research calls. A higher tier would read them.
Who is affected
Receives £500 if they accept the offer; maintains current content and income if they decline.
Has a voice · relative power: noneGains promotional exposure if the individual accepts; loses this opportunity if declined.
May lack a voice · relative power: comparableExposed to an advertisement for a product of unknown efficacy if the post is made; not exposed if declined.
May lack a voice · relative power: lessMay monitor compliance with advertising disclosure requirements if the post is made; no direct impact if declined.
May lack a voice · relative power: greaterWhat each path involves
Relative preference is different from endorsement. A perspective may rank an option highest while still objecting to it.
Accept the offer and post the advertisement for the supplement brand.
- Ranked highest by
- No complete perspective ranking
- Negative appraisal from
- Utilitarian (Act) · Care Ethics · Contractualism (Scanlon) · Deontological (Kantian) · Ubuntu (African Relational Ethics) · Virtue Ethics (Aristotelian)
Decline the offer and do not post the advertisement.
- Ranked highest by
- Utilitarian (Act) · Care Ethics · Contractualism (Scanlon) · Deontological (Kantian) · Ubuntu (African Relational Ethics) · Virtue Ethics (Aristotelian)
- Negative appraisal from
- No recorded negative appraisal
Explore suggested tradeoffs
Model-written interpretations, not verified predictions. Check them against the people and constraints in your situation.
Option A
- Potential benefit
- £500 in immediate financial gain for the individual.
- Potential cost
- Diffuse but real harms to followers: potential misinformation, wasted money on ineffective or unsafe products, and erosion of trust in the individual’s judgment. The cost is borne by the followers, not the individual.
- Who bears it
- The individual’s followers, who may rely on the individual’s implicit endorsement and suffer financial, health, or relational consequences.
Option B
- Potential benefit
- Preservation of trust, relational integrity, and personal integrity. The individual avoids contributing to the broader problem of unverified supplement promotion, which harms public health and consumer trust.
- Potential cost
- The £500 financial opportunity and any potential future collaborations with the brand. The cost is borne by the individual, who forgoes immediate gain.
- Who bears it
- The individual, who loses the financial benefit and may face short-term reputational or professional consequences.
Compare experimental decision rules
These formulas reuse the same scores. They are sensitivity checks, not independent confirmations. Equal ranges do not establish comparable moral units.
Option B leads under 5 of 5 rules. This does not make it the right choice.
Consensus
highest confidence-weighted mean. Highest: B
Maximin
highest floor across seats. Highest: B
Weighted
per-seat weights applied. Highest: B
Unanimity
only options no seat scores below zero. Highest: B
Vulnerability
weighted toward seats centring the least-powerful party. Highest: B
Confidence weighting uses model-reported application confidence. Vulnerability weighting uses hand-assigned tradition weights, not measured burdens. These assumptions need independent review.
Original synthesis and audit record
The original is preserved and may contradict the structured comparisons. Those comparisons establish rankings, not philosophical correctness.
Model-written, as recorded
Do not post the advertisement for the supplement brand.
The traditions agree on the outcome but for distinct reasons. The utilitarian seat totals the aggregate harm—financial loss, wasted time, or health risks to followers—and finds it outweighs the £500 gain. Contractualism and Kantian ethics refuse to aggregate at all: each follower who might be misled or harmed gets to object as an individual, and the individual’s maxim treats followers as means to an end. Care ethics and Ubuntu focus on the relational breach: promoting an unverified product erodes trust and creates discord in the web of relationships that constitute the individual and their followers. Virtue ethics judges the act by its expression of character: a person of practical wisdom would not habituate themselves to prioritizing financial gain over truthfulness, even if labeled as an advertisement.
Whether the supplement is effective and safe. If the individual could verify the product’s efficacy and safety through third-party testing (e.g., NSF Certified for Sport, USP Verified) or transparent sourcing, the council’s verdict would likely shift. The lack of this information is the primary reason the traditions unanimously reject the promotion.
All original synthesis fields
{
"headline": "Do not post the advertisement for the supplement brand.",
"whyThisOne": "Every ethical tradition on the council—utilitarian, care ethics, contractualism, Kantian, Ubuntu, and virtue ethics—agrees that promoting a product of unknown efficacy and safety, even with transparency, risks harming followers, breaches trust, and expresses a deficiency in integrity. The financial gain does not justify the diffuse but real harms: misinformation, wasted resources, or potential health risks to those who rely on the individual’s judgment. The council’s verdict is unanimous and robust: the costs outweigh the benefits, and the decision is clear.",
"theDissent": "None. All traditions converged on declining the offer, though care ethics and virtue ethics were the most emphatic, scoring the choice to decline as actively positive rather than merely neutral. Their dissent would emerge only if the product’s safety and efficacy were independently verified.",
"crux": "Whether the individual’s financial gain justifies the risk of harm to followers when promoting a product of unknown efficacy and safety, even with transparency.",
"whereTheyPartCompany": "The traditions agree on the outcome but for distinct reasons. The utilitarian seat totals the aggregate harm—financial loss, wasted time, or health risks to followers—and finds it outweighs the £500 gain. Contractualism and Kantian ethics refuse to aggregate at all: each follower who might be misled or harmed gets to object as an individual, and the individual’s maxim treats followers as means to an end. Care ethics and Ubuntu focus on the relational breach: promoting an unverified product erodes trust and creates discord in the web of relationships that constitute the individual and their followers. Virtue ethics judges the act by its expression of character: a person of practical wisdom would not habituate themselves to prioritizing financial gain over truthfulness, even if labeled as an advertisement.",
"tradeoffs": [
{
"optionId": "a",
"whatYouGain": "£500 in immediate financial gain for the individual.",
"whatItCosts": "Diffuse but real harms to followers: potential misinformation, wasted money on ineffective or unsafe products, and erosion of trust in the individual’s judgment. The cost is borne by the followers, not the individual.",
"whoBearsTheCost": "The individual’s followers, who may rely on the individual’s implicit endorsement and suffer financial, health, or relational consequences."
},
{
"optionId": "b",
"whatYouGain": "Preservation of trust, relational integrity, and personal integrity. The individual avoids contributing to the broader problem of unverified supplement promotion, which harms public health and consumer trust.",
"whatItCosts": "The £500 financial opportunity and any potential future collaborations with the brand. The cost is borne by the individual, who forgoes immediate gain.",
"whoBearsTheCost": "The individual, who loses the financial benefit and may face short-term reputational or professional consequences."
}
],
"decisiveUncertainty": "Whether the supplement is effective and safe. If the individual could verify the product’s efficacy and safety through third-party testing (e.g., NSF Certified for Sport, USP Verified) or transparent sourcing, the council’s verdict would likely shift. The lack of this information is the primary reason the traditions unanimously reject the promotion.",
"whatYouProbablyDidNotKnow": [
"A 2019 analysis of 272 herbal and dietary supplements found that 51% did not match their labels when chemically tested, though this study focused on a higher-risk clinical context.",
"A 2022 study tested 50 probiotic and dairy products and found that 12 contained undeclared species or were missing species listed on the label.",
"Only 54% of supplement brands (4,268 out of 7,882) in a recent database have verified third-party testing from recognized programs like NSF, USP, or Informed Sport.",
"A 2023 study in *JAMA Network Open* found that 776 dietary supplements contained undeclared pharmaceutical ingredients, including prescription drugs, banned stimulants, and steroids.",
"ConsumerLab analysis found that roughly 1 in 4 supplements either failed to contain the amount of active ingredient listed on the label or contained concerning levels of contaminants.",
"NOW Foods tested 22 St. John’s Wort supplements purchased from Amazon in 2025 and found that all except one failed potency testing, with nine containing synthetic dyes and five having no detectable hypericin (the key active compound).",
"NOW Foods tested 25 Methyl B-12 supplements in 2025 and found that 12 brands tested below 100% of their label claim, with three brands containing 0-1% potency.",
"NOW Foods tested 24 SAM-e supplements in 2024 and found that 20 brands failed potency testing, with 16 containing less than 20% of the labeled potency and six containing zero potency."
]
}Model: mistral/mistral-large-latest · 2026-08-22T17:40:44.243Z
Procedure structure: passed. Philosophical correctness and source authority have not been certified.
Recording provenance and original caveats
£500 for a product you have never taken · recorded 2026-08-22
Every seat scores taking the money at −65 or worse. The research turns an honesty question into a safety one on the way there. Recorded 2026-08-22. Captured live off the wire, 582s end to end. ZERO movement in Round 3 — no seat moved, so no seat could credit a challenge. That is the honest outcome for a case with nothing to dispute, and the corpus needs one: a set of runs where the delta always moves would give a false impression of how often cross-examination changes anything. Five of six seats scored taking the money at exactly −65. Identical scores across five different procedures are not proof of collapse — the adherence gate passed and the traces differ — but they are the shape a collapse would also take, and on an easy case that is worth a reader's suspicion rather than their trust. 65 findings and ZERO contested claims, on a topic where the sources are unusually consistent. Compare source-or-prisoner, where 56 findings produced three contested claims because the sources could not agree how many states have shield laws.